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Ethylene Receptors Sense More than Strain
PAGE 313
Ethylene, the simplest alkene, is a plant hormone that influences fruit ripening, developmental processes, stress response, and senescence.
Initial hormone perception requires presence of ethylene receptors, such as ETR1, where ethylene binds to a copper(I) cofactor located in the
receptor’s sensor domain. Although ethylene is a molecule of high symmetry, Pirrung et al. now show that its receptor exhibits selectivity for
asymmetric ligands. The finding is surprising but consistent with an asymmetric, protein-based receptor. The authors also shed new light on
the mechanism of action of 1-methylcylopropene, an ETR1 antagonist that involves unexpected chemical modification of the receptor. Fur-
thermore, the study defines the molecular basis of the high binding affinities of alkene ligands for the copper-containing ethylene receptors in
higher plants.
Selected from the Pak
PAGE 322
Lack of target specificity is a common drawback of kinase inhibitors
that target the conserved ATP-binding pocket. Nonconserved regula-
tory elements found in some kinases may offer alternative targets for
more selective kinase inhibition. Deacon et al. report the identification
of IPA-3, a highly selective small-molecule inhibitor that targets the
Pak kinase autoregulatory mechanism. Biochemical studies suggest
that IPA-3 may trap a transient intermediate step in Pak activation,
and cell-based experiments demonstrate selective inhibition of Pak in
live cells. These results suggest that screening assays that recapitulate
biologically important regulatory mechanisms may reveal novel oppor-
tunities for kinase inhibition.
Hammerhead Ribozyme: Just Add
Water
PAGE 332
Hammerhead ribozymes catalyze the RNA phosphodiester isomeriza-
tion reaction, leading to an RNA self-cleavage. The molecular mechanism of the catalysis has been extensively debated. The structure of
the full-length ribozyme confirmed the role of two invariant nucleotides, G12 and G8, as the general base and the general acid, but did
not address the role of solvent molecules and divalent ions. Martick et al. now present new structural data on the full-length hammerhead
ribozyme in the presence of manganese ions, Mn2+, which led to improved resolution and solvent ordering, thus revealing the presence of
potentially catalytically important water molecules in the active site. The authors suggest that the ordered solvent moleculesmight participate
in a proton transfer relay or assist in activating the general acid and base.
Breaking the Aminergic GPCRs Drug Design Code
PAGE 343
Despite the successful development of numerous drugs that can regu-
late the activity of aminergic G-protein coupled receptors (GPCRs), the
underlying principles for developing activators and/or inhibitors are not
well understood. Tan et al. applied the rotamer toggle switch model
of GPCR activation toward a design of agonists and antagonists of
TAAR1, an orphan GPCR. This approach proved fruitful and resulted
in rational design and synthesis of rTAAR1 superagonists and lead
antagonists. The strategy might be generally useful for deciphering the
code to aminergic GPCR drug design by providing a conceptual frame-
work for understanding the relationship between themolecular structure
of a drug and its pharmacological properties. (Figure adopted from file
provided by Tan et al.)
Mimicking Host Defense Peptides
PAGE 354
In the era of increasing antibacterial resistance and ‘‘super bugs,’’ low molecular weight peptide-based compounds, termed host defense
peptides (HDPs) are increasingly recognized as a potential source for new antimicrobial agents. Radzishevsky et al. now describe biophysical
properties of a library of 103 HDP mimics, oligo-acyl-lysines (OAKs). OAKs present an innovative intercalation of polar and hydrophobic
residues, with a sequence that can be varied to produce quasi-unlimited alternatives. Therefore, OAKs design provides an efficient tool
for dissecting the parameters believed to be crucial for HDPs activity. The work provides a robust basis for future investigations and contains
a library with a wealth of bioactive HDP-mimetics.Chemistry & Biology 15, April 2008 ª2008 Elsevier Ltd All rights reserved ix
Chemistry & Biology
In This IssueHalting Candida’s Poly(A) Polymerase
PAGE 363
Using a C. albicans-based chemogenomics approach, Jiang et al. have screened
collections of crude natural product extracts and identified a novel antifungal com-
pound, parnafungin, which disrupts 30 mRNA processing by specifically inhibiting
the poly(A) polymerase activity. Parnafungin displays potent and broad-spectrum
activity against diverse clinically relevant fungal pathogens and in vivo efficacy in
a murine model of candidiasis. This work demonstrates how functional genomics
and chemical-genetic strategies can be applied directly in a fungal pathogen and
used to efficiently exploit the potential of natural products for antifungal lead
discovery. (Figure adopted from file provided by Jiang et al.)
Mitochondria Ahoy!
PAGE 375
Mitochondria are important targets for cancer chemotherapy and other disease treatments. Gaining access to this organelle is not trivial. The
inner mitochondrial space is separated from the cytoplasm by a system of two membranes: outer and inner mitochondrial membrane (OMM
and IMM, respectively). OMM is similar to the plasma membrane, and it can be expected that compounds that can penetrate plasma mem-
brane can also penetrate OMM.However, IMM is notoriously impenetrable and posses a serious challenge for the design and development of
mitochondria-specific therapeutics. Here, Horton et al. report a rational development of mitochondrial transporters: synthetic cell-permeable
peptides that are able to enter mitochondria. These mitochondria-penetrating peptides (MPPs) exhibit efficient cellular uptake and specific
localization to the mitochondria of living cells.
Vitamin D Receptor Agonist Go Super
PAGE 383
Vitamin D nuclear receptor (VDR) belongs to a superfamily of steroid/thyroid hormone/retinoid nuclear receptors and acts as a ligand-
dependent transcription factor to control multiple biological responses. Its malfunction leads to a number of disease states. Although avail-
able, 1a,25-dihydroxyvitamin D3 analogs don’t have significant clinical relevance. Therefore, Hourai et al. set out to generate newVDR ligands
using the knowledge of the crystal structure of VDR bound to its natural ligand. They present synthesis, in vitro, and in vivo characterization
of designed VDR superagonist ligands and demonstarate that one of the new compounds exhibits improved properties and activity in mice.
The two crystal structures of VDR with newly produced ligands provide an explanation for the observed transactivation potency.
‘‘Hot Spot’’ Gets it Done
PAGE 393
Williams et al. applied a two-phase ‘‘hot spot’’ saturation muta-
genesis strategy to rapidly evolve the specificity of themacrolide
glycosyltransferase OleD toward a nonnatural coumarin anti-
biotic acceptor, novobiocic acid. Incredibly, even in the absence
of a high-throughput screen for glycosylation of novobiocic
acid, this approach led to the rapid identification of a variant
glycosyltransferase with a several-hundred fold improvement
in catalytic activity, which was mirrored by an improvement in
promiscuity toward glycosyl donor substrates. The work high-
lights the potential for developing ‘‘designer: glycosyltrans-
ferases for a wide range of drugs and drug leads. (Figure credits:
Williams et al.)
FabH Posts Clear Enter and Exit
Signs
PAGE 402
Mycobacterium tuberculosis is the causative agent of tuberculo-
sis, one of the deadliest contemporary infectious diseases. Long
fatty acids, mycolic acids, are abundant cell wall components of
M. tuberculosis and their biosynthesis represents an attractive drug target. A key step in this process is catalyzed by an enzyme, FabH, and
involves sequestering a long carbon chain deep within the binding pocket. The available FabH structure suggests that the binding necessi-
tates chain threading through a long and twisted passageway. Now Sachdeva et al. demonstrate that the FabH exists in an open form which
permits binding and release of long carbon chain substrates, inhibitors, and product without laborious twisting and threading. The authors
predicted similar large-scale movements for other enzymes involved in mycolic acid biosynthesis.x Chemistry & Biology 15, April 2008 ª2008 Elsevier Ltd All rights reserved
